Vincent-Salomon A - Search Results

1

Tumor antigens and antigen-presenting capacity in breast cancer.

McDermott RS, Beuvon F, Pauly M, Pallud C, Vincent-Salomon A, Mosseri V, Pouillart P, Scholl SM. McDermott RS, et al. Pathobiology. 2002-2003;70(6):324-32. doi: 10.1159/000071272. Pathobiology. 2002. PMID: 12865628

2

EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition.

Romero P, Richart L, Aflaki S, Petitalot A, Burton M, Michaud A, Masliah-Planchon J, Kuhnowski F, Le Cam S, Baliñas-Gavira C, Méaudre C, Luscan A, Hamza A, Legoix P, Vincent-Salomon A, Wassef M, Holoch D, Margueron R. Romero P, et al. Nat Commun. 2024 Apr 24;15(1):3452. doi: 10.1038/s41467-024-47701-x. Nat Commun. 2024. PMID: 38658543 Free PMC article.

3

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.

Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P. Fizazi K, et al. Cancer. 1996 Apr 1;77(7):1315-23. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4. Cancer. 1996. PMID: 8608509 Clinical Trial.

4

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P. Sastre-Garau X, et al. Cancer. 1996 Jan 1;77(1):113-20. doi: 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8. Cancer. 1996. PMID: 8630916

5

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer.

Rozan S, Vincent-Salomon A, Zafrani B, Validire P, De Cremoux P, Bernoux A, Nieruchalski M, Fourquet A, Clough K, Dieras V, Pouillart P, Sastre-Garau X. Rozan S, et al. Int J Cancer. 1998 Feb 20;79(1):27-33. doi: 10.1002/(sici)1097-0215(19980220)79:1<27::aid-ijc6>3.0.co;2-y. Int J Cancer. 1998. PMID: 9495354

6

Human papillomavirus genotype as a major determinant of the course of cervical cancer.

Lombard I, Vincent-Salomon A, Validire P, Zafrani B, de la Rochefordière A, Clough K, Favre M, Pouillart P, Sastre-Garau X. Lombard I, et al. J Clin Oncol. 1998 Aug;16(8):2613-9. doi: 10.1200/JCO.1998.16.8.2613. J Clin Oncol. 1998. PMID: 9704710

7

[Herceptin, a monoclonal humanized antibody anti-HER2: a major therapeutic progress in breast cancers overexpressing this oncogene?].

Beuzeboc P, Scholl S, Garau XS, Vincent-Salomon A, Cremoux PD, Couturier J, Palangié T, Pouillart P. Beuzeboc P, et al. Bull Cancer. 1999 Jun;86(6):544-9. Bull Cancer. 1999. PMID: 10417428 Free article. Review. French.

8

Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies.

de Cremoux P, Martin EC, Vincent-Salomon A, Dieras V, Barbaroux C, Liva S, Pouillart P, Sastre-Garau X, Magdelenat H. de Cremoux P, et al. Int J Cancer. 1999 Oct 8;83(2):157-61. doi: 10.1002/(sici)1097-0215(19991008)83:2<157::aid-ijc2>3.0.co;2-l. Int J Cancer. 1999. PMID: 10471520 Clinical Trial.

9

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy.

Vincent-Salomon A, Carton M, Freneaux P, Palangie T, Beuzeboc P, Mouret E, de Crémoux P, Coué O, Zafrani B, Nicolas A, Clough K, Fourquet A, Pouillart P, Sastre-Garau X. Vincent-Salomon A, et al. Eur J Cancer. 2000 Mar;36(5):586-91. doi: 10.1016/s0959-8049(99)00339-1. Eur J Cancer. 2000. PMID: 10738122

10

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer.

Scholl SM, Balloul JM, Le Goc G, Bizouarne N, Schatz C, Kieny MP, von Mensdorff-Pouilly S, Vincent-Salomon A, Deneux L, Tartour E, Fridman W, Pouillart P, Acres B. Scholl SM, et al. J Immunother. 2000 Sep-Oct;23(5):570-80. doi: 10.1097/00002371-200009000-00007. J Immunother. 2000. PMID: 11001550 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters